Issue · May 2026New this week: evidence-first longevity readsThe newsletter — one essay, Sunday morningsArchive access — every article, free to readPodcast coming soon — NotebookLM sessionsLetters from readers — reply to any emailIssue · May 2026New this week: evidence-first longevity readsThe newsletter — one essay, Sunday morningsArchive access — every article, free to readPodcast coming soon — NotebookLM sessionsLetters from readers — reply to any email
Edited for you

Recommendations for the week ahead

Browse the full archive →
FilterSort
The GLP-1 Side Effect List Your Doctor Probably Won't Mention
Weight Loss

The GLP-1 Side Effect List Your Doctor Probably Won't Mention

Most patients on Ozempic, Wegovy, or Zepbound hear about nausea and stop there. The full safety profile includes lean muscle loss, sulfur burps, gallstones, NAION vision risk, anesthesia warnings, and more. A research-grounded guide to what gets left out of the 15-minute appointment.

Apr 27 · 16 min read
The long read

A slower piece, on one thing.

All long reads →
The Stubborn Belly Fat Peptide: Why Tesamorelin Is Going Viral with Women Over 40
Weight Loss · In-depth essay

The Stubborn Belly Fat Peptide: Why Tesamorelin Is Going Viral with Women Over 40

Tesamorelin is trending as a midlife belly-fat peptide, but the FDA approval, the 18% visceral-fat number, and the cancer warnings tell a more complicated story for women over 40.

Begin reading14 min read
Letter from the editorial team

On the quiet parts of getting well.

BPC-157 safety is not settled.

Learn what human studies, cancer concerns, and product-quality risks mean before first use.

The goal isn’t to be comfortable with change — it’s to be comfortable with one small change, on a schedule, held for a year.

From “Is BPC-157 Safe? A Full Risk Breakdown for First-Time Users” · The HL Benefits Editorial Team · May 2026
By topic

What we’re reading across the desks.

See all categories →
The Quiet Podcast · Coming soon

Notebook-LM reads the magazine — deep-dive conversations, weekly.

We’re recording with NotebookLM. Expect a deep-dive and a short-form version of each issue’s best essays, delivered to your favorite podcast app when we launch.

42 min · launching soonSubscribe to get the first episode
The daily read · Free

One essay, every morning. No theatre.

A short email with the day’s best piece, a quote we’re sitting with, and links we actually read. No upsell, no course. Unsubscribe in one click.

458Essays

By subscribing, you agree to our privacy policy.